Santé log9h
Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings
Poster Presentation American Rhinologic Society (ARS) 2024 Annual Meeting Title: Efficacy and safety of LYR-210 for CRS from the pivotal Phase 3 ENLIGHTEN 1 trial Presenting Author: Vineeta Belanger, ...
Santé log9h
ImPact Biotech Announces 50% Enrollment in Phase 3 ENLIGHTED Clinical Trial of Padeliporfin VTP in Low Grade Upper Tract Urothelial Cancer
ImPact Biotech shared interim results at the American Society of Clinical Oncology 2024 in June in which 10 of the 13 (77%) response-evaluable patients achieved a CR at the end of ITP. The company is ...
Santé log9h
Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
The pre-funded warrants and the warrants will be exercisable upon shareholder approval. The pre-funded warrants will be exercisable at a price of $0.0001 per share until exercised in full. The ...
Santé log9h
Information on the total number of voting rights and shares
Total number of securities carrying voting rights: 34,389,015 (all ordinary shares) Total number of voting rights (= denominator): 34,389,015 (all relating to ordinary shares) ...
Santé log9h
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
About Dupixent Dupixent is available in China in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin (subcutaneous ...
Santé log9h
Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines
Zembrace® SymTouch® (sumatriptan succinate injection) 10mg is indicated for the acute treatment of migraine in adults CHATHAM, N.J., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding ...
Santé log9h
Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed
The LungFit ® PH system is an innovative device designed to generate Nitric Oxide (NO) from room air and deliver NO for the treatment of persistent pulmonary hypertension in neonates (PPHN), a ...
Santé log9h
Lexicon to Present Phase 3 Trial Design for Sotagliflozin in Hypertrophic Cardiomyopathy (HCM) at Upcoming Medical Congress
“SONATA-HCM will evaluate the efficacy of sotagliflozin, a dual SGLT2 and SGLT1 inhibitor, on symptoms, function, and other patient-reported outcomes, as well as safety in patients with symptomatic ...
Santé log9h
Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction
We continue to execute on our transformation plan and today’s transaction brings us another step closer to optimizing our capital structure and debt profile for the business,” said Rajiv De Silva, ...
Santé log9h
Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities
Boehringer Ingelheim has entered a partnership with the NCD Alliance, a network dedicated to shaping a world in which everyone can live a healthy and productive life, free from the preventable ...
Santé log9h
33 Medical Wins 2024 Best Technology in Spine Award for Innovative NuvoDisc® Device
Designed with patient outcomes in mind, NuvoDisc ® offers a minimally invasive treatment option, reducing the need for complex and extensive surgeries. Patients with degenerative disc disease often ...
Santé log9h
WeightWatchers Announces Executive Leadership Transition
Ms. Comonte joined the WeightWatchers Board of Directors in June 2023. In connection with this announcement, the WeightWatchers Board of Directors has been reduced from nine to eight members.